Back to search
Liver Cirrhosis, Biliary
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Liver Cirrhosis, Biliary trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Liver Cirrhosis, Biliary trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The present phase 1b/2 randomised, double-blind, placebo-controlled, two-part study is designed to evaluate the safety, tolerability, pharmacokinetic characteri…
To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.
Background: One way to treat liver cancer is to deliver chemotherapy drugs only to the liver (and not to the whole body). Researchers want to see if adding the…
The participants of this study will have confirmed Primary Biliary Cholangitis (PBC) and cirrhosis (scarring of the liver). PBC is a slowly progressive disease…
This study will collect information from participants with Primary Biliary Cholangitis (PBC) as they use the drug elafibranor in real world setting. PBC is a p…
The goal of this registry is to better understand how primary biliary cholangitis develops over time, including the role of disease-related biomarkers, complica…
Study to investigate the efficacy and safety of two doses of K-808 (pemafribate) in subjects with PBC.
This is an open-label, non-comparator, global, multi-center, long-term safety study for evaluating safety and tolerability of linerixibat in participants with c…